Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database

被引:0
|
作者
Yusuke Kan
Junko Nagai
Yoshihiro Uesawa
机构
[1] Meiji Pharmaceutical University,Department of Medical Molecular Informatics
[2] Nanohana Pharmacy,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Adverse effects can occur owing to anorexia, which can reduce treatment compliance and worsen the patients overall condition. One such side effect, namely drug-induced taste and smell disorders, reduces patients quality of life. Although antibiotics can cause taste and smell disorders, a few studies have examined antibiotic-induced taste and smell disorders. Therefore, this study comprehensively analyzed the relationship between taste and smell disorders and antibiotic usage. The side effects of antibiotics were investigated using the FDA Adverse Event Reporting System database (FAERS). The reporting odds ratios between the listed drugs and taste and smell disorders P values were comprehensively calculated. Adjusted odds ratios were calculated to account for patient background. Furthermore, to clarify the feature of this adverse effect, shape parameters indicating the expression pattern were calculated. Signals that induced taste and smell disorders were detected for six antibiotics, including drugs for which this event is not described in the package insert in Japan. Multiple logistic regression analysis suggested an association of taste and smell disorders with gender, hypertension, mental disorder, and cancer. The median time to onset of antibiotic-induced taste and smell disorders was 2–5 days. Six antibiotics could be analyzed, and four of these drugs matched those with detected signals. Our study supported previous findings on gender and age. Furthermore, antibiotic-induced taste and smell disorders are likely to develop in the early stage of treatment. For these reasons, it is important to remember the risk of developing of taste and smell disorders when administering antibiotics. In addition, it is recommended that the patient be monitored carefully for at least 1 week before initiating treatment, and the patients course should be followed for at least 2 months.
引用
收藏
相关论文
共 50 条
  • [1] Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database
    Kan, Yusuke
    Nagai, Junko
    Uesawa, Yoshihiro
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] Evaluation of the Expression Profile of Antibiotic-Induced Thrombocytopenia Using the Japanese Adverse Drug Event Report Database
    Asai, Yuki
    Yamamoto, Takanori
    Abe, Yasuharu
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2021, 40 (06) : 542 - 550
  • [3] Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
    Morris, Robert
    Ali, Rahinatu
    Cheng, Feng
    [J]. CURRENT DRUG TARGETS, 2024, 25 (07) : 454 - 464
  • [4] DRUG-INDUCED ACUTE RENAL FAILURE USING THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Alhammad, A. M.
    Al Hawaj, M. A.
    Alsalman, A. J.
    Alhashem, Y. N.
    Harpe, S. E.
    Smith, W. R.
    Brophy, D. F.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A74 - A74
  • [5] An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study
    Shiraishi, Chihiro
    Kato, Hideo
    Ogura, Toru
    Iwamoto, Takuya
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [6] An evaluation of the FDA adverse event reporting system and the potential for reporting bias
    Monnot, Andrew D.
    Fung, Ernest S.
    Compoginis, Goli S.
    Towle, Kevin M.
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (06) : 1849 - 1854
  • [7] Assessing taxane-associated adverse events using the FDA adverse event reporting system database
    Lao, Dong-Hui
    Chen, Ye
    Fan, Jun
    Zhang, Jian-Zhong
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (12) : 1471 - 1476
  • [8] Reporting of Neoplasms Following Angiotensin Receptor Blocker Recalls Using the FDA Adverse Event Reporting System Database
    Sedgh, Robert Cohen
    Moon, Jungyeon
    Jackevicius, Cynthia
    [J]. CIRCULATION, 2020, 142
  • [9] An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
    Hsin-wei Wang
    Alan M. Hochberg
    Ronald K. Pearson
    Manfred Hauben
    [J]. Drug Safety, 2010, 33 : 1117 - 1133
  • [10] An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
    Wang, Hsin-wei
    Hochberg, Alan M.
    Pearson, Ronald K.
    Hauben, Manfred
    [J]. DRUG SAFETY, 2010, 33 (12) : 1117 - 1133